SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision

Do P2RX7 antagonists selectively block pathogenic exosomes while preserving beneficial microglial functions?

PARTIALLY ADDRESSED

The debate highlighted P2RX7's dual role in both harmful exosome secretion and beneficial microglial responses. The critical therapeutic window between suppressing tau spread and maintaining neuroprotection remains undefined. Source: Debate session sess_SDA-2026-04-03-gap-tau-prop-20260402003221 (Analysis: SDA-2026-04-03-gap-tau-prop-20260402003221)

Priority: 0.90 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: Do P2RX7 antagonists selectively block pathogenic exosomes while preserving beneficial microglial functions? is a 0.9 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Do P2RX7 antagonists selectively block pathogenic exosomes while preserving beneficial microglial functions? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (9)

P2RX7→Exosome SecretionGPX4→P2RX7P2RX7→STINGACHE→P2RX7HSP90→P2RX7
▸ Show 4 more

antagonizes (1)

H3→P2RX7

associated with (5)

P2RX7→Glucose HomeostasisP2RX7→Glycemic TraitsP2RX7→Type 2 Diabetes MellitusP2RX7→Type 2 DiabetesP2RX7→microglial neuroprotection

causes (2)

P2RX7→STINGP2RX7→Tau Propagation

contributes to (2)

P2RX7→Brain AtrophyP2RX7→Neurodegeneration

expressed in (8)

P2RX7→LUNG TISSUEP2RX7→PANCREATIC B-CELLSP2RX7→IMMUNE CELLSP2RX7→pancreatic beta cellsP2RX7→Lung Tissue
▸ Show 3 more

expresses (5)

CCL2→P2RX7OLIGODENDROCYTE→P2RX7OLIGODENDROCYTES→P2RX7HSP90→P2RX7ASTROCYTE→P2RX7

inhibits (4)

OLIGODENDROCYTE→P2RX7OLIGODENDROCYTES→P2RX7NEURONS→P2RX7P2RX7→P2RY12

involved in (2)

P2RX7→extracellular nucleotide signalingP2RX7→purinergic signaling

no GWAS AD association (1)

PMID_31187411→P2RX7

regulates (5)

P2RX7→Extracellular VesiclesP2RX7→Glucose HomeostasisP2RX7→GLUCOSE HOMEOSTASISP2RX7→Glucose MetabolismP2RX7→baseline phagocytic function

risk factor for (1)

P2RX7→Diabetes

targets (1)

h-0758b337→P2RX7

targets gene (1)

h-1333080b→P2RX7

therapeutic target (1)

P2RX7→THERAPEUTIC_TARGET

upregulates (2)

P2RX7→UPREGULATESP2RX7→COVID-19
🕑 Activity Feed
✏ update on knowledge_gap by max_gmail 2026-04-26T18:31
✏ update on knowledge_gap by None 2026-04-25T22:15
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps